Physician profile
Thinh Q Vo
NPI 1043251044
$1,009.66
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $484 · 2020: $444 · 2021: $81.91.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $282.52 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $192.88 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $144.00 | 2019-2020 | |
| Advanced Respiratory, INC | $76.88 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $46.40 | 2019-2021 | |
| United Therapeutics Corporation | $39.95 | 2019 | |
| Insmed, INC. | $36.97 | 2019 | |
| Nabriva Therapeutics, Plc | $23.72 | 2020 | |
| Glaxosmithkline, LLC. | $23.00 | 2020 | |
| Mylan Specialty L.P. | $22.73 | 2019 | |
| Harmony Biosciences LLC | $21.00 | 2020 | |
| Novo Nordisk INC | $19.63 | 2021 | |
| Sunovion Pharmaceuticals INC. | $19.35 | 2019 | |
| La Jolla Pharmaceutical Company | $18.25 | 2020 | |
| Grifols USA, LLC | $15.60 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.86 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.92 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thinh Vo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.